- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04330898
Patients With Implantable Cardiac Devices Requiring a Nuclear Magnetic Resonance (RESONANCE)
Spanish Registry of Patients With Implantable Cardiac Devices That Require a Diagnostic Imaging Test With Nuclear Magnetic Resonance
Study Overview
Status
Intervention / Treatment
Detailed Description
MRI is currently infra indicated in patients with cardiac stimulation devices and for this reason, the request for this imaging technique in these patients is complicated and, often, the MRI-based test is replaced by a CT scan that may not be so beneficial for the diagnosis.
Current data indicate that, with cardiological control and maintaining basic safety precautions, MRI could be performed in patients with peacemakers and Implantable Cardioverter Defibrillators (ICD) that require it for clinical reasons, although it should be noted that currently, due to lack of data published, the absolute safety of an MRI in these patients and the protocol used in each case cannot be guaranteed.
This registry proposal is to have data of all patients implanted with Biotronik cardiac stimulation devices and evaluate how many of them have an indication for an MRI-based diagnostic test, how many of them are already undergoing this diagnostic test, how many are given an tomography as an alternative to avoid subjecting patients to an MRI
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Alicante, Spain
- Recruiting
- Hospital General de Alicante
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Contact:
- Marta Barbacid Hernández, PhrmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Principal Investigator:
- Juan Gabriel Martinez, Cardiology
-
Sub-Investigator:
- Raquel Ajo Ferrer, Cardiology
-
Alicante, Spain
- Recruiting
- Hospital San Juan de Alicante
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Contact:
- Marta Barbacid Hernández, PharmD,MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Principal Investigator:
- Vicente Bartomeu Gonzalez, Cardiology
-
Barakaldo, Spain
- Recruiting
- Hospital de Cruces
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirico, PhamTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Principal Investigator:
- Ignacio Andres Bodegas Canas, Cardiology
-
Sub-Investigator:
- I;into Sauna Godoy, MD,Cardiology
-
Barcelona, Spain
- Recruiting
- Hospital Clinic
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Principal Investigator:
- Jose Maria Tolosana, Cardiology
-
Sub-Investigator:
- Rodolfo San Antonio, Cardiology
-
Barcelona, Spain
- Recruiting
- Hospital De Bellvitge
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Principal Investigator:
- Ignasi Anguera Camós, Cardiology
-
Sub-Investigator:
- Marcos Rodriguez, Cardiology
-
Madrid, Spain
- Recruiting
- Hospital Puerta de Hierro
-
Principal Investigator:
- Ignacio Fernández Lozano, Cardiologist
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirirco, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Sub-Investigator:
- Diego Jiménez Sánchez, Cardiologist
-
Marbella, Spain
- Recruiting
- Hospital Costa del Sol
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Principal Investigator:
- Francisco Ruiz Mateas, MD
-
Málaga, Spain
- Recruiting
- Hospital Virgen de la Victoria
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34 645494281
- Email: cchirico@trialance.com
-
Contact:
- Marta Barbacid, PharmD, MSc
- Phone Number: +34 630767668
- Email: mbarbacid@trialance.com
-
Principal Investigator:
- Javier Alzueta Rodríguez, Cardiologist
-
Sub-Investigator:
- Thor Cruzado Maldonado, Cardiologist
-
-
Madrid
-
Cáceres, Madrid, Spain, 28015
- Recruiting
- Hospital San Pedro de Alcantara
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Principal Investigator:
- Maria Jose Garcia Ramos, Cardiology
-
El Ejido, Madrid, Spain, 28015
- Recruiting
- Hospital de Poniente
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Contact:
- Marta B Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Principal Investigator:
- Javier Fierro Rosón, Intensivist
-
Sub-Investigator:
- Sofía García Ordoñez, Intensivist
-
Sub-Investigator:
- Emilio Robles-Musso Castillo, Intensivist
-
Sub-Investigator:
- Miguel Angel Fernández Ibáñez, Intensivist
-
Sub-Investigator:
- Francisco Javier Vasserot Vargas, Intensivist
-
Ferrol, Madrid, Spain, 28015
- Recruiting
- Hospital Arquitecto Marcide
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Principal Investigator:
- Fernando Garcia Lopez, Cardiology
-
Sub-Investigator:
- Emiliano Fernandez/Obama Windscheid, Cardiology
-
Galdakao, Madrid, Spain, 28015
- Recruiting
- Hospital de Galdakano
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta B Chirico, PharmD, MSc
- Phone Number: +34645494281
- Email: cchirico@trilance.com
-
Principal Investigator:
- Javier Zumalde Otegui, Cardiology
-
Sub-Investigator:
- Alaitz Romero, Cardiology
-
Sub-Investigator:
- German Zugazabeitia, Cardiology
-
Orense, Madrid, Spain, 28015
- Recruiting
- Hospital de Orense
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Principal Investigator:
- Marcos Antonio Perez Veloso, Cardiology
-
Sub-Investigator:
- Beariz Gonzalez Chana, Cardiology
-
Oviedo, Madrid, Spain, 28015
- Recruiting
- Hospital General De Asturias
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Principal Investigator:
- Jose Manuel Rubin Lopez, Cardiology
-
Sub-Investigator:
- Daniel Garcia Iglesias, Cardiology
-
Sub-Investigator:
- Diego Perez Diez, Cardiology
-
Sub-Investigator:
- David Calvo Cuervo, Cardiology
-
Plasencia, Madrid, Spain, 28015
- Not yet recruiting
- Hospital Virgen Del Puerto
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Principal Investigator:
- David Rodriguez Palomo, Cardiology
-
Puerto Real, Madrid, Spain, 28015
- Recruiting
- Hospital de Puerto Real
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Contact:
- Marta Barbacid Hernández, ParmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Principal Investigator:
- Francisco Javier Lozano Cid, Cardiology
-
Sub-Investigator:
- Pablo Jose Gonzalez Perez, Cardiology
-
Sabadell, Madrid, Spain, 28015
- Recruiting
- Hospital Parc Taul'i
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Contact:
- Marta B Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Principal Investigator:
- Gabriel Gusi Tragant, Cardiologist
-
Sub-Investigator:
- Jordi Puntí Sala, Cardiologist
-
Sub-Investigator:
- Antoni Martínez Rubio, Cardiologist
-
Sub-Investigator:
- Jesus Ignaci Juménez Lopez, Cardiologist
-
Santander, Madrid, Spain, 28015
- Recruiting
- Hospital Marques de Valdecilla
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494981cchiric
- Email: cchirico@trialance.com
-
Principal Investigator:
- Juan Jose Olalla, Cardiology
-
Sub-Investigator:
- Susana Gonzalez, Cardiology
-
Valladolid, Madrid, Spain, 28015
- Recruiting
- Hospital Rio Hortega
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Principal Investigator:
- Benito Herreros, Cardiology
-
Sub-Investigator:
- Sergio Madero, Cardiology
-
Vitoria, Madrid, Spain, 28015
- Recruiting
- Hospital Universitatis de Araba
-
Contact:
- Marta Barbacid Hernández, PharmD, MSc
- Phone Number: +34630767668
- Email: mbarbacid@trialance.com
-
Contact:
- Concetta Chirico, PharmTechD
- Phone Number: +34645494281
- Email: cchirico@trialance.com
-
Principal Investigator:
- Maria Robledo Iniarritu, Cardiology
-
Sub-Investigator:
- Jon Orruño, Cardiology
-
Sub-Investigator:
- Santiago Garcia Mancebo, Cardiology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients carrying a cardiac stimulation device
- Patients able to understand the nature of the procedure
- Patients who give informed consent
Exclusion Criteria:
- Epicardial cables
- Abandoned cables
- Non-BIOTRONIK cables
- Age <18 years
- Pregnant and breastfeeding
- Subjects with irreversible brain damage caused by a pre-existing brain disease
- Heart transplant 6 months prior to recruitment or expected within the next 3 months
- Cardiac surgery 3 months prior to recruitment or planned for the next 3 months
- Life expectancy less than 12 months
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of patients with implantable cardiac devices that require a diagnostic test based on MRI
Time Frame: 1 year
|
statistical analysis of the variable
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary indication for MRI
Time Frame: 1 year
|
statistical analysis of the variable
|
1 year
|
|
Reasons for not used MRI
Time Frame: 1 year
|
statistical analysis of the variable
|
1 year
|
|
Percentage of patients with a non-MRI-based test diagnosis, although they had an indication for an MRI-based diagnostic test because of their disease
Time Frame: 1 year
|
statistical analysis of the variable
|
1 year
|
|
Cost effectiveness of the he MRI Autodetect function
Time Frame: 1 year
|
statistical analysis of the variable
|
1 year
|
|
Analysis of the differences in the workflow
Time Frame: 1 year
|
statistical analysis of the variable
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Francisco Javier Alzueta, MD, PhD, Hospital Virgen de la Victoria
- Principal Investigator: Francisco Ruiz Mateas, MD, PhD, Hospital Costa del Sol
Publications and helpful links
General Publications
- Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ. 2006 Oct 10;175(8):911-7. doi: 10.1503/cmaj.060566.
- Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994 Mar;96(3):200-9. doi: 10.1016/0002-9343(94)90143-0.
- Kanal E, Borgstede JP, Barkovich AJ, Bell C, Bradley WG, Etheridge S, Felmlee JP, Froelich JW, Hayden J, Kaminski EM, Lester JW Jr, Scoumis EA, Zaremba LA, Zinninger MD; American College of Radiology. American College of Radiology White Paper on MR Safety: 2004 update and revisions. AJR Am J Roentgenol. 2004 May;182(5):1111-4. doi: 10.2214/ajr.182.5.1821111. No abstract available.
- Gold MR, Sommer T, Schwitter J, Al Fagih A, Albert T, Merkely B, Peterson M, Ciuffo A, Lee S, Landborg L, Cerkvenik J, Kanal E; Evera MRI Study Investigators. Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study. J Am Coll Cardiol. 2015 Jun 23;65(24):2581-2588. doi: 10.1016/j.jacc.2015.04.047. Epub 2015 May 14.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- RMN01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Implantable Cardiac Device. Patients With a NMR Indication
-
National Taiwan University Hospital Hsin-Chu BranchCompletedPatients With Cardiac Implantable Electronic DevicesTaiwan
-
Englewood Hospital and Medical CenterMedtronicCompletedUtility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillatorsPatients With a Generation 2 Medtronic Implantable Cardioverter-defibrillator(ICD)United States
-
CMC Ambroise ParéWithdrawnCompare Two Programming Modalities for CRT Devices in Heart Failure Patients With an Indication for Cardiac Resynchronization TherapyMonaco, France
-
Chinese Academy of Medical Sciences, Fuwai HospitalRecruitingConsented to Participate in the Trial and Signed an ICF | Patients With an Indication for PM Implantation or CRTPChina
-
LivaNovaCompletedPatients Implanted With a PacemakerKorea, Republic of, France, Spain, Germany, Japan, Portugal, Denmark, United States, Belgium, Canada, Italy
-
Hospices Civils de LyonActive, not recruitingAdult Patients Managed in a Cardiac Critical Care Unit With a Pathology Requiring at Least One Potentially Painful and Anxiety-provoking Invasive ProcedureFrance
-
Hospices Civils de LyonNot yet recruitingVCO2 Variation in Intensive Care as a Marker of Fluid Responsiveness | Cardiac Index Variation Transpulmonary Thermodilution in Patients on Controlled Ventilation With ShockFrance
Clinical Trials on Biotronik peacemakers, implantable cardioverter-defibrillators and cardiac resynchronizers
-
Beth Israel Deaconess Medical CenterUniversity of Colorado, Denver; Mayo Clinic; University of Pennsylvania; Emory... and other collaboratorsEnrolling by invitationImplantable Defibrillator UserUnited States
-
Barts & The London NHS TrustQueen Mary University of London; Boston Scientific CorporationCompletedImplantable Defibrillator User | Hypertrophic Cardiomyopathy | Ventricular Arrythmia | Implantable Cardioverter Ventricular Lead Dysfunction or ComplicationUnited Kingdom
-
Charite University, Berlin, GermanyLeipzig Heart Science gGmbHRecruitingMyocardial Infarction | Sudden Cardiac DeathCzechia, Israel, Spain, Germany, Austria, France, United Kingdom, Netherlands, Hungary, Poland, Belgium, Denmark, Martinique
-
University Hospital Southampton NHS Foundation...University of Southampton; British Heart FoundationRecruiting
-
Biotronik, Inc.University of ZurichTerminatedHeart Failure | Ventricular DyssynchronyUnited States, Denmark, Israel, Germany, Australia, United Kingdom, Netherlands, France, Belgium, Czechia, Italy, Austria, Spain, Poland, Canada, Portugal, Switzerland
-
Sheba Medical CenterIsraeli Association for Cardiovascular Trials - IACTCompleted
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of California... and other collaboratorsRecruitingHeart Failure and Reduced Ejection FractionUnited States
-
Boston Scientific CorporationCompleted
-
Boston Scientific CorporationCompleted
-
Cheng-Hsin General HospitalCompletedHeart Failure | HypotensionTaiwan